Recombinant Human DLL4 Fc Chimera (Catalog # 10185‑D4)enhances Recombinant Human BMP-2 (Catalog # 355-BM) induced alkalinephosphatase activity in the C3H10T1/2 mouse embryonic fibroblast cell line. TheED50 for ...read more
2 μg/lane of Recombinant Human DLL4 Fc Chimera was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® blue staining, showing bands at 88-98 kDa and 170-190 kDa, ...read more
Recombinant Human DLL4 Fc Chimera Protein, CF Summary
Details of Functionality
Measured by the ability of the immobilized protein to enhance BMP-2 induced alkaline phosphatase activity in C3H10T1/2 mouse embryonic fibroblast cells. Nobta, M. et al. (2005) J. Biol. Chem. 280:15842. The ED50 fort his effect is 0.02-0.12 μg/mL.
Source
Human embryonic kidney cell, HEK293-derived human DLL4 protein
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Note
<0.10 EU per 1 μg of the protein by the LAL method.
Applications/Dilutions
Dilutions
Bioactivity
Theoretical MW
81 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
SDS-PAGE
88-98 kDa, under reducing conditions
Publications
Read Publications using 10185-D4 in the following applications:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
3 months, -20 to -70 °C under sterile conditions after reconstitution.
Buffer
Lyophilized from a 0.2 μm filtered solution in PBS.
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Reconstitution Instructions
Reconstitute at 250 μg/mL in PBS.
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Recombinant Human DLL4 Fc Chimera Protein, CF
Delta 4 precursor
delta 4
delta ligand 4
delta4
delta-like 4 (Drosophila)
delta-like 4 homolog (Drosophila)
delta-like 4 homolog
delta-like 4 protein
delta-like protein 4
DLL4
Drosophila Delta homolog 4
hdelta2
MGC126344
notch ligand delta-2
notch ligand DLL4
Background
Delta-like
protein 4 (DLL4) is a type I membrane protein belonging to the
Delta/Serrate/Lag2 (DSL) family of Notch ligands (1). Notch signaling is an
evolutionarily conserved pathway that controls cell fate and is required in
multiple developmental processes including vascular development, hematopoiesis,
somatogenesis, myogenesis, and neurogenesis (2-4). Dysregulation in the Notch
pathway is associated with various human diseases. In mammals, four Notch
homologs (Notch 1 to 4) and five ligands (DLL 1, 3 and 4, Jagged 1 and 2) have
been identified. Notch ligands are transmembrane proteins with a DSL motif
necessary for Notch binding, tandem EGF repeats, a transmembrane region and a
short intracellular domain (ICD). Notch ligands are categorized into two subfamilies
based on the presence of an extracellular cysteine-rich domain and insertions
that interrupt some EGF repeats in the Jagged but not the Delta ligand family.
Interactions of Notch receptors with their ligands results in reciprocal
regulated intramembrane proteolysis (RIP) (4). RIP is a mechanism for
transmembrane signal transduction that involves the sequential processing by a
disintegrin metalloprotease (ADAM) and then by presenilin/ gamma secretase,
resulting in shedding of the extracellular domains and the generation of the
soluble ICD signaling fragments, respectively. The Notch ICD translocates to
the nucleus and interacts with transcriptional coactivators, resulting in the
transcription of target genes. The ICDs of the Notch ligands have also been
shown to translocate to the nucleus where they may have a signaling function
(5, 6). DLL4 is expressed highly and selectively within the arterial
endothelium and has been shown to function as a ligand for Notch 1 and Notch 4.
Human and mouse DLL4 share 86% amino acid sequence identity (1).
Shutter, J.R. et al. (2000) Genes Dev. 14:1313.
Iso, Tatsuya et al. (2002) Arterioscler. Thromb. Vasc. Biol. 23:543.
Walker, L. et al. (2001) Stem Cells 19:543.
Baron, M. (2002) Semin. Cell Dev. Biol. 14:113.
Ikeuchi, T. and S.S. Sisodia (2003) J. Biol. Chem. 278:7751.
Bland, C.E. et al. (2003) J. Biol. Chem. 278:13607.
New DLL4 Vaccine May Prevent Breast Tumors We at Novus Biologicals have a large antibody database devoted to signalling pathways. These underpin every area of molecular biological research, including cancer. Among our cell signalling antibodies is one targeted to DLL4 (Delta-like protein 4). D... Read full blog post.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our Recombinant Human DLL4 Fc Chimera Protein, CF and receive a gift card or discount.